APOMORPHINE WOCKHARDT, APOWOK (Wockhardt Bio Pty Ltd)
Product name
APOMORPHINE WOCKHARDT, APOWOK
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
176 working days (255)
Active ingredients
apomorphine hydrochloride hemihydrate
Registration type
New generic medicine
Indication
APOMORPHINE WOCKHARDT/APOWOK (solution for injection or infusion) is indicated to reduce the number and severity of "off" phases in patients with Parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy.